Yan Shi
Affiliations: | University of South Florida, Tampa, FL, United States |
Google:
"Yan Shi"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Patel RS, Lui A, Hudson C, et al. (2023) Small molecule targeting long noncoding RNA GAS5 administered intranasally improves neuronal insulin signaling and decreases neuroinflammation in an aged mouse model. Scientific Reports. 13: 317 |
Shi Y, Lee C, Sang P, et al. (2022) /Sulfono--AA peptide hybrids agonist of GLP-1R with prolonged action both and . Acta Pharmaceutica Sinica. B. 13: 1648-1659 |
Shi Y, Li H, Nachman RJ, et al. (2022) Insecticidal efficacy and risk assessment of different neuropeptide analog combinations against the peach-potato aphid following topical exposure. Pest Management Science |
Zhong J, Guo Y, Lu S, et al. (2022) Rational design of a sensitivity-enhanced tracer for discovering efficient APC-Asef inhibitors. Nature Communications. 13: 4961 |
Sang P, Shi Y, Wei L, et al. (2022) Helical sulfono-γ-AApeptides with predictable functions in protein recognition. Rsc Chemical Biology. 3: 805-814 |
Huang B, Zhou L, Liu R, et al. (2022) Activation of E6AP/UBE3A-Mediated Protein Ubiquitination and Degradation Pathways by a Cyclic γ-AA Peptide. Journal of Medicinal Chemistry |
Teng P, Zheng M, Cerrato DC, et al. (2021) The folding propensity of α/sulfono-γ-AA peptidic foldamers with both left- and right-handedness. Communications Chemistry. 4: 58 |
Sang P, Zeng H, Lee C, et al. (2021) α/Sulfono-γ-AApeptide Hybrid Analogues of Glucagon with Enhanced Stability and Prolonged In Vivo Activity. Journal of Medicinal Chemistry |
Wei L, Gao R, Wang M, et al. (2021) Dimeric lipo-α/sulfono-γ-AA hybrid peptides as broad-spectrum antibiotic agents. Biomaterials Science. 9: 3410-3424 |
Shi Y, Sang P, Cai J. (2021) Discovery of α-helix-mimicking sulfono-γ-AApeptides as p53-MDM2 inhibitors. Future Medicinal Chemistry. 0 |